Biotech · Public company · Somerset, NJ, US

Legend Biotech Corp

Ticker LEGN · SEC CIK 0001801198

Track this companyFree. Adds Legend Biotech Corp to your Dealase workspace and tells you when its record changes.

Clinical trials32 recruiting or active

Pipeline programs3From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline3

DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Jul 26, 2023ClinicalTrials.gov NCT05680922 · fetched Nov 12, 2026
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic AdenocarcinomaPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 18, 2023ClinicalTrials.gov NCT05539430 · fetched Nov 12, 2026
Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell LymphomaPHASE1 · UNKNOWN · started Sep 13, 2021ClinicalTrials.gov NCT04712864 · fetched Nov 12, 2026